Imaging localised dynamic changes in the nucleus accumbens following nicotine withdrawal in rats
暂无分享,去创建一个
[1] H. Lal,et al. A comparison of narcotic analgesics with neuroleptics on behavioral measures of dopaminergic activity. , 1975, Life sciences.
[2] Mark R. Symms,et al. Functional Magnetic Resonance Neuroimaging of Drug Dependence: Naloxone-Precipitated Morphine Withdrawal , 2002, NeuroImage.
[3] N. Volkow,et al. Inhibition of monoamine oxidase B in the brains of smokers , 1996, Nature.
[4] H. Fibiger,et al. Lack of tolerance to nicotine-induced dopamine release in the nucleus accumbens. , 1989, European journal of pharmacology.
[5] J. Lake,et al. Rodent model of nicotine abstinence syndrome , 1992, Pharmacology Biochemistry and Behavior.
[6] J. Lake,et al. Naloxone precipitates nicotine abstinence syndrome in the rat , 1993, Psychopharmacology.
[7] G. Crelier,et al. Investigation of BOLD signal dependence on cerebral blood flow and oxygen consumption: The deoxyhemoglobin dilution model , 1999, Magnetic resonance in medicine.
[8] C. -. Lu,et al. Levels of immunoreactive dynorphin A1-13 during development of morphine dependence in rats. , 1998, Zhongguo yao li xue bao = Acta pharmacologica Sinica.
[9] P. Carlier,et al. Simultaneous measurement of perfusion and oxygenation changes using a multiple gradient-echo sequence: application to human muscle study. , 1998, Magnetic resonance imaging.
[10] T. Svensson,et al. Behavioral manifestations of the nicotine abstinence syndrome in the rat: peripheral versus central mechanisms , 1997, Psychopharmacology.
[11] G. Bock,et al. Ciba Foundation Symposium 152 - The Biology of Nicotine Dependence , 1990 .
[12] A. Simmons,et al. Functional magnetic resonance imaging of the acute effect of intravenous heroin administration on visual activation in long-term heroin addicts: results from a feasibility study. , 1997, Drug and alcohol dependence.
[13] P. Clarke,et al. Mesolimbic dopamine activation--the key to nicotine reinforcement? , 2007, Ciba Foundation symposium.
[14] G. Di Chiara,et al. Dissociation of physical abstinence signs from changes in extracellular dopamine in the nucleus accumbens and in the prefrontal cortex of nicotine dependent rats. , 2000, Drug and alcohol dependence.
[15] S. Matta,et al. Nicotine stimulates the expression of cFos protein in the parvocellular paraventricular nucleus and brainstem catecholaminergic regions. , 1993, Endocrinology.
[16] M. Benwell,et al. Evidence that Tobacco Smoking Increases the Density of (−)‐[3H]Nicotine Binding Sites in Human Brain , 1988, Journal of neurochemistry.
[17] Karl J. Friston,et al. Statistical parametric maps in functional imaging: A general linear approach , 1994 .
[18] O. Salminen,et al. Effect of Acute Nicotine on Fos Protein Expression in Rat Brain During Chronic Nicotine and Its Withdrawal , 2000, Pharmacology Biochemistry and Behavior.
[19] Stephen M Smith,et al. Fast robust automated brain extraction , 2002, Human brain mapping.
[20] N. Bruggen,et al. Biomedical Imaging in Experimental Neuroscience , 2002 .
[21] M. Schmid,et al. Effects of nicotine withdrawal on central dopaminergic systems , 1996, Pharmacology Biochemistry and Behavior.
[22] S. Hyman,et al. Acute Effects of Cocaine on Human Brain Activity and Emotion , 1997, Neuron.
[23] T. Svensson,et al. Reduced dopamine output in the nucleus accumbens but not in the medial prefrontal cortex in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome , 1998, Brain Research.
[24] E. London,et al. Effects of nicotine on local cerebral glucose utilization in the rat , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[25] P. Flecknell,et al. Laboratory animal anaesthesia , 1996 .
[26] Joseph B. Mandeville,et al. Pharmacologic Magnetic Resonance Imaging (phMRI) , 2002 .
[27] S. Ogawa,et al. Oxygenation‐sensitive contrast in magnetic resonance image of rodent brain at high magnetic fields , 1990, Magnetic resonance in medicine.
[28] K. Chergui,et al. Nicotine injections into the ventral tegmental area increase locomotion and Fos-like immunoreactivity in the nucleus accumbens of the rat , 1996, Brain Research.
[29] K. Perkins,et al. Acute tolerence to nicotine in smokers: lack of dissipation within 2 hours , 1995, Psychopharmacology.
[30] P. Clarke,et al. Blockade of nicotinic receptor‐mediated release of dopamine from striatal synaptosomes by chlorisondamine and other nicotinic antagonists administered in vitro , 1994, British journal of pharmacology.
[31] G. Di Chiara,et al. Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats. , 1986, European journal of pharmacology.
[32] I. Stolerman,et al. The neurobiology of tobacco addiction. , 1991, Trends in pharmacological sciences.
[33] C. Chiamulera,et al. The Reinforcing Properties of Nicotine are Associated with a Specific Patterning of c‐fos Expression in the Rat Brain , 1996, The European journal of neuroscience.
[34] B R Rosen,et al. Detection of dopaminergic neurotransmitter activity using pharmacologic MRI: Correlation with PET, microdialysis, and behavioral data , 1997, Magnetic resonance in medicine.
[35] L. Pellegrino,et al. stereotaxic atlas of the rat brain , 1967 .
[36] W. Kuschinsky,et al. Effects of nicotine withdrawal on the local cerebral glucose utilization in conscious rats , 1991, Brain Research.
[37] G. Koob,et al. Dramatic decreases in brain reward function during nicotine withdrawal , 1998, Nature.
[38] C. Chiamulera,et al. Common Neural Substrates for the Addictive Properties of Nicotine and Cocaine , 1997, Science.
[39] T. Svensson,et al. Behavioral and Biochemical Manifestations of Mecamylamine-Precipitated Nicotine Withdrawal in the Rat: Role of Nicotinic Receptors in the Ventral Tegmental Area , 1999, Neuropsychopharmacology.
[40] Betty Jo Salmeron,et al. Pharmacological applications of magnetic resonance imaging. , 2002, Psychopharmacology bulletin.
[41] Rainer Spanagel,et al. Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway , 1992 .
[42] Douglas C. Noll,et al. Suppression of Vascular Artifacts in Functional Magnetic Resonance Images Using MR Angiograms , 1998, NeuroImage.
[43] P. Clarke,et al. Nicotinic binding in rat brain: autoradiographic comparison of [3H]acetylcholine, [3H]nicotine, and [125I]-alpha-bungarotoxin , 1985, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[44] Karl J. Friston,et al. Analysis of fMRI Time-Series Revisited—Again , 1995, NeuroImage.
[45] R. Spanagel. Modulation of drug-induced sensitization processes by endogenous opioid systems , 1995, Behavioural Brain Research.
[46] O. Salminen,et al. Expression of fos protein in various rat brain areas following acute nicotine and diazepam , 1996, Pharmacology Biochemistry and Behavior.
[47] G. Koob,et al. Reward and somatic changes during precipitated nicotine withdrawal in rats: centrally and peripherally mediated effects. , 2000, The Journal of pharmacology and experimental therapeutics.
[48] M. Jarvis,et al. The scientific case that nicotine is addictive , 2005, Psychopharmacology.
[49] T. Svensson,et al. Selective c‐fos induction and decreased dopamine release in the central nucleus of amygdala in rats displaying a mecamylamine‐precipitated nicotine withdrawal syndrome , 2000, Synapse.
[50] M. Bock,et al. The relationship between the BOLD‐induced T2 and T 2* : A theoretical approach for the vasculature of myocardium , 1999, Magnetic resonance in medicine.
[51] R S Balaban,et al. Challenges in small animal noninvasive imaging. , 2001, ILAR journal.
[52] M. Reivich,et al. THE [14C]DEOXYGLUCOSE METHOD FOR THE MEASUREMENT OF LOCAL CEREBRAL GLUCOSE UTILIZATION: THEORY, PROCEDURE, AND NORMAL VALUES IN THE CONSCIOUS AND ANESTHETIZED ALBINO RAT 1 , 1977, Journal of neurochemistry.
[53] E. London,et al. Effects of chronic nicotine on cerebral glucose utilization in the rat , 1990, Brain Research.
[54] A. Markou,et al. Increased GABA neurotransmission via administration of gamma‐vinyl GABA decreased nicotine self‐administration in the rat , 2002, Synapse.
[55] T. George,et al. Mecamylamine: new therapeutic uses and toxicity/risk profile. , 2001, Clinical therapeutics.
[56] M. James,et al. Pharmacological magnetic resonance imaging: a new application for functional MRI. , 2000, Trends in pharmacological sciences.
[57] R G Hoffmann,et al. Nicotine-induced limbic cortical activation in the human brain: a functional MRI study. , 1998, The American journal of psychiatry.
[58] W. Corrigall,et al. GABA mechanisms in the pedunculopontine tegmental nucleus influence particular aspects of nicotine self-administration selectively in the rat , 2001, Psychopharmacology.